Dysbiosis exists in unaffected relatives of inflammatory bowel disease (IBD): emphasising the critical phases in the developmental trajectory of gut microbiota

IF 23 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Gut Pub Date : 2024-12-23 DOI:10.1136/gutjnl-2024-333425
Jingwan Zhang
{"title":"Dysbiosis exists in unaffected relatives of inflammatory bowel disease (IBD): emphasising the critical phases in the developmental trajectory of gut microbiota","authors":"Jingwan Zhang","doi":"10.1136/gutjnl-2024-333425","DOIUrl":null,"url":null,"abstract":"Inflammatory bowel disease (IBD) has emerged as a global disease, affecting individuals of every ethnicity and age groups worldwide.1 It is broadly accepted that the greatest single risk factor for the development of IBD is having an affected family member.2 First-degree relatives (FDRs) of patients with IBD have approximately a 10-fold greater likelihood of developing the disease than the general population. Despite the fact that numerous studies have been deliciated towards exploring the possible determinants that participated in, the underlying aetiology remains elusive. Amalgamation of both genetic predisposition and environmental exposures have been widely recognised as the predominant factors that instigate and drive the course of IBD. On this basis, they may also serve as contributing factors to the familial occurrence of IBD. Given that the family members of patients with IBD represent a specific population enduring this dual challenges over an extended period, it is of great concern to recognise whether undesirable alterations have manifested in these clinically asymptomatic relatives. Among numerous possibilities, changes of gut microbiome may be the overarching mechanism via which these two risk factors mediate their effect on IBD. A comprehensive understanding of gut microbiome alterations among unaffected relatives will advance our elucidation of the complexities underlying the familial aggregation of IBD. In Gut , Jacobs et al examined the gut dysbiosis and consequential functional dysregulation in members from high-risk IBD families with age spectrum from birth to senescence.3 In derivation cohort comprised 387 individuals from multiplex IBD family and 51 individuals from control families, an IBD-associated pattern of gut dysbiosis, which defined from their prior research, was observed among unaffected members from multiplex IBD families. Such dysbiosis manifested from birth with the character of delayed microbiome maturation in infants born to mothers with IBD in the early life. Starting from late …","PeriodicalId":12825,"journal":{"name":"Gut","volume":"40 1","pages":""},"PeriodicalIF":23.0000,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gut","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/gutjnl-2024-333425","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Inflammatory bowel disease (IBD) has emerged as a global disease, affecting individuals of every ethnicity and age groups worldwide.1 It is broadly accepted that the greatest single risk factor for the development of IBD is having an affected family member.2 First-degree relatives (FDRs) of patients with IBD have approximately a 10-fold greater likelihood of developing the disease than the general population. Despite the fact that numerous studies have been deliciated towards exploring the possible determinants that participated in, the underlying aetiology remains elusive. Amalgamation of both genetic predisposition and environmental exposures have been widely recognised as the predominant factors that instigate and drive the course of IBD. On this basis, they may also serve as contributing factors to the familial occurrence of IBD. Given that the family members of patients with IBD represent a specific population enduring this dual challenges over an extended period, it is of great concern to recognise whether undesirable alterations have manifested in these clinically asymptomatic relatives. Among numerous possibilities, changes of gut microbiome may be the overarching mechanism via which these two risk factors mediate their effect on IBD. A comprehensive understanding of gut microbiome alterations among unaffected relatives will advance our elucidation of the complexities underlying the familial aggregation of IBD. In Gut , Jacobs et al examined the gut dysbiosis and consequential functional dysregulation in members from high-risk IBD families with age spectrum from birth to senescence.3 In derivation cohort comprised 387 individuals from multiplex IBD family and 51 individuals from control families, an IBD-associated pattern of gut dysbiosis, which defined from their prior research, was observed among unaffected members from multiplex IBD families. Such dysbiosis manifested from birth with the character of delayed microbiome maturation in infants born to mothers with IBD in the early life. Starting from late …
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
Gut
Gut 医学-胃肠肝病学
CiteScore
45.70
自引率
2.40%
发文量
284
审稿时长
1.5 months
期刊介绍: Gut is a renowned international journal specializing in gastroenterology and hepatology, known for its high-quality clinical research covering the alimentary tract, liver, biliary tree, and pancreas. It offers authoritative and current coverage across all aspects of gastroenterology and hepatology, featuring articles on emerging disease mechanisms and innovative diagnostic and therapeutic approaches authored by leading experts. As the flagship journal of BMJ's gastroenterology portfolio, Gut is accompanied by two companion journals: Frontline Gastroenterology, focusing on education and practice-oriented papers, and BMJ Open Gastroenterology for open access original research.
期刊最新文献
Correction: The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells Are histamine-2 receptor antagonists a reasonable comparator: comparing apples and apples? Dysbiosis exists in unaffected relatives of inflammatory bowel disease (IBD): emphasising the critical phases in the developmental trajectory of gut microbiota Redefining QUAIDE: paving the way for better AI in preclinical endoscopy Is the biogeography of the mucosa-associated microbiota a key factor affecting primary sclerosing cholangitis disease course and treatment?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1